Ultrasound confirmation of correct urinary Foley catheter position and catheter patency
๐ซง
Swirl Sign
๐ง
Saline Test
๐
USG Report
USG
Positive Bladder Swirl Sign refers to visualization of mobile echogenic swirling echoes or turbulence within the urinary bladder lumen during real-time ultrasound after gentle saline instillation through a urinary catheter. It helps confirm that the catheter tip is correctly placed inside the bladder and that the catheter is patent.
Ultrasound Features of Positive Bladder Swirl Sign:
Main Finding: FINDINGS:
Real-time ultrasound demonstrates mobile echogenic swirling echoes within the urinary bladder lumen following gentle saline instillation through the urinary catheter. The finding confirms intravesical entry of instilled fluid.
CONCLUSION:
Positive bladder swirl sign.
RECOMMENDATION:
Correct catheter position and catheter patency are confirmed sonographically.
Bladder Lumen: Adequately distended or partially distended urinary bladder. Catheter Tip / Balloon: Catheter balloon may be visualized within the bladder lumen when adequately inflated. Swirling Echoes: Mobile echogenic turbulence appears immediately after saline injection. Color Doppler: Not mandatory; grayscale real-time visualization is usually sufficient. Perivesical Region: No extravesical fluid collection should be seen. Key Diagnostic Clue: Echogenic swirling movement inside bladder after saline flush confirms catheter communication with bladder lumen.
Short Report Line: Positive bladder swirl sign is seen following saline instillation through the urinary catheter, confirming correct intravesical catheter position and catheter patency.
Detailed Report Line: Real-time ultrasound demonstrates mobile echogenic swirling turbulence within the urinary bladder lumen following gentle saline instillation through the Foley catheter. The catheter balloon/tip is seen within the bladder lumen. No extravesical fluid collection is identified. Findings confirm correct intravesical catheter placement and catheter patency.
Technique / How to Demonstrate Bladder Swirl Sign:
1. Scan suprapubic region in transverse and longitudinal planes. 2. Identify urinary bladder lumen and catheter balloon if visible. 3. Attach sterile saline syringe to catheter sampling/irrigation port as per local protocol. 4. Gently instill small amount of sterile saline while observing bladder in real time. 5. Look for mobile echogenic swirling echoes within bladder lumen. 6. Positive sign means saline is entering bladder through the catheter. 7. Absence of swirl may suggest obstruction, malposition, kink, empty bladder, poor acoustic window, or technical failure. 8. Avoid excessive pressure during saline instillation. 9. Correlate with urine drainage, clinical status, and catheter function. 10. If doubt persists, repeat scan after repositioning or clinical catheter check.
Differential / Don’t Miss:
Catheter Malposition: FINDINGS:
Catheter balloon may not be visualized within bladder lumen. No intravesical swirl is seen after saline instillation. Bladder may remain distended despite catheter placement.
CONCLUSION:
Findings may suggest catheter malposition or non-functioning catheter.
RECOMMENDATION:
Clinical catheter reassessment/repositioning is advised.
Blocked Catheter: FINDINGS:
Bladder is distended with absent or poor urine drainage. No clear intravesical swirling echoes are seen during saline flush.
CONCLUSION:
Possibility of catheter blockage/kinking should be considered.
RECOMMENDATION:
Catheter flushing, replacement, or urology review may be required depending on clinical condition.
Extravesical Fluid / Suspected False Passage: FINDINGS:
Fluid is seen outside the bladder or catheter balloon is not confidently intravesical. Intravesical swirl is absent or equivocal.
CONCLUSION:
Extravesical catheter position or urethral injury cannot be excluded.
RECOMMENDATION:
Stop forceful instillation and obtain urgent clinical/urology correlation.
Key Point: Positive intravesical swirl + catheter balloon/tip within bladder + no extravesical fluid strongly supports correct catheter placement.
Important Reporting Points — Don’t Miss Anything:
1. Mention bladder distension status. 2. Mention catheter balloon/tip position if visible. 3. Mention saline instillation was performed under real-time ultrasound. 4. State whether intravesical swirling echoes are present or absent. 5. Confirm catheter patency when swirl is positive. 6. Mention absence of extravesical fluid collection. 7. Mention bladder wall abnormality, clot, debris, or stone if seen. 8. Mention residual urine/bladder distension if clinically relevant. 9. Mention limitation if bowel gas, obesity, empty bladder, or poor window affects assessment. 10. Recommend clinical catheter correlation if findings are equivocal.
FINDINGS: Urinary bladder is visualized on suprapubic ultrasound. Foley catheter balloon/tip is seen within the bladder lumen. On gentle saline instillation through the urinary catheter, mobile echogenic swirling echoes are demonstrated within the bladder lumen, consistent with a positive bladder swirl sign. No extravesical fluid collection is identified.
IMPRESSION: Positive bladder swirl sign, confirming correct intravesical urinary catheter position and catheter patency.
RECOMMENDATION: No immediate catheter repositioning is required based on ultrasound findings. Clinical correlation with urine drainage is advised.
LIMITATION: Assessment may be limited by poor bladder distension, bowel gas, obesity, patient discomfort, or inability to adequately visualize the catheter balloon/tip.
Case Study
Patient: Adult patient with poor urine drainage after Foley catheter placement.
Ultrasound Findings: Urinary bladder is visualized. Foley catheter balloon is seen within the bladder lumen. Following gentle saline instillation through the catheter, mobile echogenic swirling echoes are seen within the bladder lumen. No extravesical fluid collection is noted.
Diagnosis: Positive Bladder Swirl Sign.
Teaching Point: Real-time visualization of intravesical saline swirl confirms catheter communication with the urinary bladder and supports correct catheter placement.
SonoAcademy Digital MCQ Examination
Topic: Positive Bladder Swirl Sign
Total Questions: 10 | Total Marks: 10 | Time: 30 Minutes
Instruction: Enter your details, start the exam, answer all questions, and download your PDF marksheet after submission.
Polycystic Ovary Syndrome / Polycystic Ovarian Disease (PCOS / PCOD) is a common endocrine disorder in reproductive-age females. It is associated with chronic anovulation, menstrual irregularity, hyperandrogenism, infertility, obesity, insulin resistance, and characteristic polycystic ovarian morphology on ultrasound. Imaging helps assess ovarian morphology, ovarian volume, follicle number, stromal echogenicity, endometrial thickness, and exclude other adnexal pathology.
Ultrasound Features of PCOS / PCOD:
Ovarian Volume: FINDINGS: One or both ovaries may be enlarged. Ovarian volume greater than 10 mL supports polycystic ovarian morphology. The ovary may appear bulky with increased central stromal component. CONCLUSION: Enlarged ovarian volume supports PCOS / PCOD morphology. RECOMMENDATION: Correlation with clinical history, menstrual pattern, and hormonal profile is advised.
Multiple Small Follicles: FINDINGS: Multiple small follicles are seen in the ovary, commonly measuring 2–9 mm. Follicles may be arranged peripherally or scattered throughout the ovarian parenchyma. CONCLUSION: Multiple small ovarian follicles are suggestive of polycystic ovarian morphology. RECOMMENDATION: Clinical and biochemical correlation is recommended before labeling PCOS.
String of Pearls Appearance: FINDINGS: Multiple small follicles are arranged along the ovarian periphery, producing a characteristic “string of pearls” appearance. Central ovarian stroma may appear prominent and echogenic. CONCLUSION: Ultrasound appearance is consistent with polycystic ovarian morphology. RECOMMENDATION: Correlate with menstrual irregularity, hyperandrogenism, and endocrine profile.
Ovarian Stroma: FINDINGS: Increased central stromal echogenicity and stromal volume may be seen. The stromal component may appear relatively more prominent than follicles. CONCLUSION: Prominent echogenic ovarian stroma supports PCOS / PCOD morphology. RECOMMENDATION: Endocrine evaluation is advised.
Typical Ultrasound Criteria: 1. Ovarian volume greater than 10 mL in one or both ovaries. 2. Multiple small follicles, usually 2–9 mm in size. 3. Peripheral follicular distribution may produce “string of pearls” appearance. 4. Increased central stromal echogenicity and stromal volume may be present.
Color Doppler: May show mildly increased stromal vascularity in some cases. Endometrium: Endometrial thickness varies with menstrual cycle; prolonged anovulation may cause endometrial thickening. Adnexa: No adnexal mass should be seen in uncomplicated PCOS / PCOD. Free Fluid: Usually absent.
Finding:Both ovaries are mildly enlarged with multiple small peripheral follicles measuring approximately 2–9 mm. Increased central stromal echogenicity is noted. No adnexal mass or free fluid is seen.
Impression:Bilateral polycystic ovarian morphology suggestive of PCOS / PCOD. Clinical and hormonal correlation is advised.
Recommendation:Correlation with menstrual history, clinical evidence of hyperandrogenism, serum LH/FSH, testosterone, prolactin, TSH, fasting insulin/glucose profile, and gynecological consultation is advised.
Limitation:Ultrasound findings alone do not establish the diagnosis of PCOS. Clinical and laboratory correlation is essential.
Differential Diagnosis / Mimics:
Multifollicular Ovaries: FINDINGS: Multiple follicles are present, usually without marked stromal hypertrophy or classic peripheral distribution. CONCLUSION: May mimic PCOS but commonly occurs in puberty, recovery from hypothalamic amenorrhea, or temporary hormonal imbalance. RECOMMENDATION: Clinical and hormonal correlation is advised.
Ovarian Hyperstimulation: FINDINGS: Bilateral enlarged ovaries with multiple cystic follicles may be seen, usually following ovulation induction treatment. CONCLUSION: Findings may mimic PCOS but clinical history of fertility treatment is the key clue. RECOMMENDATION: Gynecological follow-up is advised.
Theca Lutein Cysts: FINDINGS: Bilateral multiloculated ovarian cystic enlargement may be associated with high beta-hCG states. CONCLUSION: Consider in pregnancy, molar pregnancy, or trophoblastic disease. RECOMMENDATION: Beta-hCG correlation is advised.
Androgen-Secreting Ovarian Tumor: FINDINGS: A solid ovarian mass or focal ovarian lesion may be seen with marked clinical hyperandrogenism. CONCLUSION: Should be considered when symptoms are severe, rapidly progressive, or imaging shows a focal mass. RECOMMENDATION: Further evaluation with MRI and hormonal workup is advised.
Key Point: PCOS diagnosis requires clinical, biochemical, and ultrasound correlation. Polycystic ovarian morphology alone is not equal to PCOS.
MRI Features of PCOS / PCOD:
Ovarian Size: Bilateral ovarian enlargement may be present. Follicles: Multiple small peripheral follicles are seen in the ovarian cortex. Stroma: Increased central stromal volume with low to intermediate signal intensity may be seen. T2-Weighted Imaging: Multiple small hyperintense follicles with relatively hypointense central stroma. T1-Weighted Imaging: Usually no hemorrhagic component unless associated pathology is present. Post-Contrast Imaging: Ovarian stroma may enhance; no suspicious solid mass should be present. Associated Findings: Endometrial thickening may be seen in prolonged anovulation. Key Diagnostic Clue: Bilateral enlarged ovaries with multiple small follicles and increased central stromal volume. Finding:MRI pelvis shows bilateral mildly enlarged ovaries with multiple small peripheral follicles and prominent central ovarian stroma. No suspicious adnexal mass is identified.
Impression:MRI features are suggestive of bilateral polycystic ovarian morphology.
Recommendation:Clinical and biochemical correlation is advised for diagnosis of PCOS.
Limitation:MRI is not routinely required for typical PCOS and is mainly useful when ultrasound is inconclusive or a mass is suspected.
CECT Features of PCOS / PCOD:
Role of CT: CT is not the preferred imaging modality for PCOS / PCOD. Ovarian Size: Ovaries may appear mildly enlarged bilaterally. Follicles: Multiple small follicles may be difficult to characterize accurately on CT compared with ultrasound or MRI. Stroma: Stromal assessment is limited on CT. Associated Findings: CT may incidentally show bulky ovaries or exclude other pelvic pathology. Key Diagnostic Clue: CT is usually not diagnostic; ultrasound is preferred. Finding:CT pelvis may show mildly bulky bilateral ovaries; however, follicular morphology and stromal details are better assessed on pelvic ultrasound.
Impression:CT is not the imaging modality of choice for PCOS / PCOD. Ultrasound correlation is recommended.
Recommendation:Pelvic ultrasound and hormonal correlation are advised.
Limitation:CT has limited sensitivity for follicle count and ovarian stromal assessment.
Pathology / Pathophysiology Features of PCOS / PCOD:
Nature: Endocrine-metabolic disorder affecting ovarian function. Ovulation: Chronic anovulation or oligo-ovulation is common. Hormonal Pattern: Hyperandrogenism may be present clinically or biochemically. Follicles: Multiple arrested follicles may be seen in the ovary. Stroma: Ovarian stromal hypertrophy and increased stromal activity may occur. Metabolic Association: Insulin resistance, obesity, dyslipidemia, and increased diabetes risk may be associated. Endometrium: Long-standing anovulation may increase risk of endometrial hyperplasia. Key Diagnostic Clue: Combination of menstrual irregularity, hyperandrogenism, and polycystic ovarian morphology. Finding:PCOS represents an endocrine-metabolic ovarian disorder characterized by chronic ovulatory dysfunction, hyperandrogenism, and polycystic ovarian morphology.
Impression:Clinical diagnosis supported by imaging and laboratory findings.
Recommendation:Gynecological and endocrine evaluation is advised.
Limitation:Histopathology is not required for routine diagnosis of PCOS.
Important Reporting Points:
1. Mention uterus size, shape, and myometrial echotexture. 2. Measure endometrial thickness and correlate with menstrual cycle day. 3. Mention right ovarian size and volume. 4. Mention left ovarian size and volume. 5. Describe follicle number and size range. 6. Mention peripheral follicular arrangement if present. 7. Describe ovarian stromal echogenicity and stromal prominence. 8. Comment on adnexal mass if present or absent. 9. Mention presence or absence of free fluid in pouch of Douglas. 10. Add that ultrasound findings need clinical and hormonal correlation. Short Report Template:
FINDINGS: Uterus is normal in size and echotexture. Endometrial thickness measures ____ mm. Both ovaries are mildly enlarged. Right ovary measures ____ × ____ × ____ cm with volume of ____ mL. Left ovary measures ____ × ____ × ____ cm with volume of ____ mL. Multiple small peripheral follicles measuring 2–9 mm are seen in both ovaries with increased central stromal echogenicity. No adnexal mass or free fluid is seen.
IMPRESSION: Bilateral polycystic ovarian morphology suggestive of PCOS / PCOD. Clinical and hormonal correlation is recommended.
Case Study
Patient: 24-year-old female with irregular menstrual cycles, acne, and weight gain.
Ultrasound Findings: Uterus is normal in size. Endometrial thickness measures 8 mm. Both ovaries are mildly enlarged with multiple small peripheral follicles measuring 2–9 mm. Increased central stromal echogenicity is noted bilaterally. No adnexal mass or free fluid is seen.
MRI Findings: Bilateral enlarged ovaries with multiple peripheral follicles and prominent central stroma. No suspicious adnexal mass.
Diagnosis: Bilateral polycystic ovarian morphology suggestive of PCOS / PCOD.
Teaching Point: Ultrasound supports the diagnosis but PCOS should be diagnosed only after clinical and biochemical correlation.
Video Explanation
SonoAcademy Digital MCQ Examination
Topic: PCOS / PCOD — Polycystic Ovary Syndrome
Total Questions: 10 | Total Marks: 10 | Time: 30 Minutes
Instruction: Enter your details, start the exam, answer all questions, and download your PDF marksheet after submission.
Post-Injection Gluteal Hematoma (Intramuscular) refers to bleeding within the gluteal musculature following intramuscular injection. Patients may present with pain, swelling, tenderness, ecchymosis, restricted movement, or a palpable gluteal lump. Imaging helps confirm hematoma, define extent, detect active bleeding, and differentiate it from abscess, granuloma, seroma, or soft tissue tumor.
Ultrasound Features of Post-Injection Gluteal Hematoma:
Acute Gluteal Hematoma: FINDINGS: Ultrasound examination of the gluteal region demonstrates an
ill-defined heterogeneous predominantly hyperechoic intramuscular collection
within the gluteal musculature at the site of injection. Internal echogenic
clot material is noted. No significant internal vascularity is identified
on color Doppler imaging. Mild surrounding soft tissue edema may be present.
No definite abscess formation or organized fluid collection is seen.
CONCLUSION: Ultrasound features are consistent with an acute
post-injection intramuscular gluteal hematoma.
RECOMMENDATION: Clinical correlation is advised. Conservative
management and follow-up ultrasound may be considered if symptoms
persist, swelling increases, or secondary infection is suspected.
Subacute Gluteal Hematoma: FINDINGS:
Ultrasound examination of the gluteal musculature demonstrates a heterogeneous
intramuscular collection with mixed echogenicity. Areas of hypoechogenicity
and anechoic liquefaction are present due to clot organization and breakdown.
Internal mobile echogenic debris may be seen. Mild surrounding soft tissue
edema may persist. No significant internal vascularity is identified on
color Doppler imaging.
CONCLUSION:
Ultrasound features are consistent with a subacute post-injection intramuscular
gluteal hematoma showing evolving clot organization and partial liquefaction.
RECOMMENDATION:
Clinical correlation is advised. Follow-up ultrasound may be considered to
document resolution, particularly if symptoms persist or increase in size.
Chronic Gluteal Hematoma: FINDINGS:
Ultrasound examination of the gluteal musculature demonstrates a well-defined
chronic intramuscular collection with predominantly hypoechoic to anechoic
appearance. Internal septations, echogenic fibrotic strands, and peripheral
calcifications may be present. The lesion may show a thickened capsule due
to chronic organization. Minimal surrounding soft tissue edema is noted.
No significant internal vascularity is identified on color Doppler imaging.
CONCLUSION:
Ultrasound features are consistent with a chronic post-injection intramuscular
gluteal hematoma demonstrating organized clot formation with fibrotic change
and possible peripheral calcification.
RECOMMENDATION:
Clinical correlation is advised. Follow-up ultrasound may be considered if
symptoms persist, the lesion enlarges, or there is concern for secondary
infection or other complications.
Shape:
Oval, irregular, fusiform, or elongated along muscle fibers. Margins:
Variable; may become well-defined with time. Internal Echoes:
Clot, debris, fluid-fluid level, or septations may be present.
Color Doppler:
Usually no internal vascularity. Peripheral Hyperemia:
May be present due to surrounding inflammation. Mass Effect:
Compression or separation of adjacent muscle fibers. Key Diagnostic Clue:
Avascular heterogeneous intramuscular collection at the injection site with relevant clinical history.
Finding:Heterogeneous intramuscular collection is noted within the gluteal musculature measuring approximately ____ × ____ cm. Internal echoes/debris are seen. No significant internal vascularity is demonstrated on color Doppler. Impression:Ultrasound features are suggestive of post-injection intramuscular gluteal hematoma. Recommendation:Clinical correlation is advised. Follow-up ultrasound may be performed if swelling increases, pain persists, fever develops, or secondary infection is suspected. Limitation:Assessment may be limited by obesity, deep location of the lesion, pain during probe compression, or extensive soft tissue edema.
Differential Diagnosis / Mimics:
Gluteal Abscess: FINDINGS:
Ultrasound examination of the gluteal region demonstrates a thick-walled
irregular hypoechoic to complex fluid collection within the gluteal soft
tissues or musculature. Internal low-level echoes and debris are present.
Peripheral hyperemia is demonstrated on color Doppler imaging. Adjacent
soft tissue edema and inflammatory changes may be seen. Clinical history
may be associated with localized pain, swelling, erythema, and fever.
CONCLUSION:
Ultrasound features are consistent with a gluteal abscess with associated
surrounding inflammatory changes.
RECOMMENDATION:
Clinical correlation is advised. Surgical consultation for drainage and
appropriate antibiotic therapy may be considered. MRI may be useful in
selected cases to assess the extent of disease and detect restricted
diffusion within the abscess cavity.
Injection Granuloma: FINDINGS:
Ultrasound examination of the injection site demonstrates a small,
well-defined to mildly irregular predominantly hypoechoic or heterogeneous
solid soft tissue nodule within the subcutaneous tissues or superficial
musculature. The lesion may contain internal echogenic foci related to
fibrosis or calcification. Minimal to mild internal vascularity may be
present on color Doppler imaging. No significant fluid collection is
identified.
CONCLUSION:
Ultrasound features are consistent with a chronic post-injection
granuloma (injection granuloma).
RECOMMENDATION:
Clinical correlation is advised. Conservative management is usually
appropriate. Follow-up ultrasound may be considered if the lesion
increases in size, becomes symptomatic, or demonstrates atypical imaging
features.
Soft Tissue Sarcoma (Buttock): FINDINGS:
Ultrasound examination demonstrates a heterogeneous solid soft tissue
mass within the gluteal region. The lesion may show irregular or
lobulated margins, internal vascularity on color Doppler imaging, and
areas of necrosis or cystic degeneration. A solid enhancing component
may be present. The mass demonstrates progressive enlargement on serial
imaging and does not follow the expected course of resolution seen with
post-traumatic or post-injection lesions.
CONCLUSION:
Ultrasound features are suspicious for a soft tissue sarcoma of the
gluteal region. Malignancy cannot be excluded.
RECOMMENDATION:
Further evaluation with contrast-enhanced MRI is recommended for lesion
characterization and assessment of local extent. Referral to an orthopedic
oncology or soft tissue tumor specialist is advised. Histopathological
confirmation with image-guided biopsy should be considered.
Seroma: FINDINGS:
Ultrasound examination demonstrates a well-defined anechoic to
hypoechoic fluid collection within the subcutaneous tissues or gluteal
soft tissues at the site of prior intervention or trauma. The collection
contains little to no internal echoes and lacks significant internal
septations or solid components. No internal vascularity is identified on
color Doppler imaging. Mild surrounding soft tissue edema may be present.
CONCLUSION:
Ultrasound features are consistent with a seroma, representing a simple
postoperative or post-traumatic fluid collection.
RECOMMENDATION:
Clinical correlation is advised. Conservative management is usually
sufficient. Follow-up ultrasound may be considered if the collection
enlarges, becomes symptomatic, or if superimposed infection is suspected.
Fat Necrosis: FINDINGS:
Ultrasound examination demonstrates a focal heterogeneous echogenic
lesion within the subcutaneous fat of the gluteal region. The lesion may
contain areas of fat liquefaction, internal hypoechoic components, or
coarse echogenic foci with posterior acoustic shadowing related to
dystrophic calcification. No significant internal vascularity is
identified on color Doppler imaging. Surrounding mild fibrotic changes
may be present.
CONCLUSION:
Ultrasound features are consistent with fat necrosis within the gluteal
soft tissues, likely related to prior trauma, injection, or surgery.
RECOMMENDATION:
Clinical correlation is advised. Conservative management is generally
appropriate. Follow-up imaging may be considered if the lesion enlarges,
becomes symptomatic, or demonstrates atypical features.
Myositis: FINDINGS:
Ultrasound examination of the gluteal musculature demonstrates diffuse
enlargement and increased echogenicity of the affected muscle fibers with
loss of the normal fibrillar architecture. Patchy areas of heterogeneous
echotexture and interstitial edema may be present. Mild increased
vascularity is noted on color Doppler imaging. No discrete intramuscular
hematoma, organized fluid collection, or abscess is identified.
CONCLUSION:
Ultrasound features are consistent with myositis involving the gluteal
musculature, characterized by diffuse inflammatory changes without
evidence of a focal blood collection.
RECOMMENDATION:
Clinical and laboratory correlation is advised. Consider further
evaluation with MRI if symptoms are severe, progressive, or if there is
concern for infectious myositis. Follow-up imaging may be considered
based on clinical progression.
Morel-Lavallรฉe Lesion: FINDINGS:
Ultrasound examination demonstrates a fusiform or crescent-shaped fluid
collection located between the subcutaneous fat and the underlying deep
fascia. The collection may be anechoic, hypoechoic, or heterogeneous
depending on the age of the lesion and may contain internal debris,
septations, fat globules, or fluid-fluid levels. Mild peripheral
vascularity may be present, while significant internal vascularity is
typically absent. Findings are consistent with a closed degloving injury.
CONCLUSION:
Ultrasound features are consistent with a Morel-Lavallรฉe lesion, a
post-traumatic closed degloving injury involving separation of the
subcutaneous tissues from the underlying fascia.
RECOMMENDATION:
Clinical correlation with a history of trauma is advised. MRI may be
considered for further characterization and assessment of lesion extent,
particularly in chronic or recurrent cases. Follow-up imaging may be
warranted based on symptoms and treatment response.
Pseudoaneurysm: FINDINGS:
Ultrasound examination demonstrates a well-defined pulsatile cystic
lesion adjacent to an arterial structure within the gluteal region. Color
Doppler imaging reveals characteristic bidirectional swirling blood flow
producing the classic "yin-yang" appearance. A communicating neck between
the lesion and the parent artery is identified. Spectral Doppler analysis
may demonstrate a characteristic "to-and-fro" waveform within the neck
of the pseudoaneurysm.
CONCLUSION:
Ultrasound features are consistent with a pseudoaneurysm, demonstrating
the characteristic yin-yang Doppler flow pattern and arterial neck
communication.
RECOMMENDATION:
Urgent vascular surgery or interventional radiology consultation is
advised. Further evaluation with CT angiography or MR angiography may be
considered for treatment planning. Clinical monitoring is recommended due
to the risk of enlargement, rupture, or compression of adjacent
structures.
Key Point: Recent injection history, intramuscular location, blood-product appearance, and absent internal vascularity support hematoma.
MRI Features of Post-Injection Gluteal Hematoma:
T1-Weighted Imaging: Variable signal depending on the age of blood products; subacute hematoma may show high T1 signal due to methemoglobin T2-Weighted Imaging: Heterogeneous hyperintense or mixed-signal intramuscular collection STIR / Fat-Suppressed Images: Surrounding muscular and soft tissue edema appears hyperintense Gradient Echo / SWI: Blooming artifact may be seen due to hemosiderin or blood products Post-Contrast Imaging: No solid internal enhancement; thin peripheral rim enhancement may be present Diffusion-Weighted Imaging: Usually no true restricted diffusion unless infected hematoma/abscess develops Muscle Involvement: Expansion, edema, and separation of muscle fibers may be seen Complication: Secondary infection, abscess formation, compression neuropathy, or active bleeding may occur rarely Key Diagnostic Clue: Intramuscular lesion with blood-product signal evolution and absence of enhancing solid tumor component Finding:Intramuscular collection is seen within the gluteal musculature showing heterogeneous blood-product signal intensity with surrounding muscular edema. No enhancing solid soft tissue component is identified.
Impression:MRI findings are consistent with post-injection intramuscular gluteal hematoma.
Recommendation:Follow-up imaging is advised if the lesion enlarges, fails to resolve, or shows atypical enhancement.
Limitation:Evaluation may be limited by motion artifact, poor fat suppression, lack of contrast study, or inability to correlate with injection history.
CECT Features of Post-Injection Gluteal Hematoma:
Non-Contrast CT: Hyperdense or mixed-density intramuscular collection depending on blood age
Contrast CT: Hematoma usually shows no internal enhancement
Active Bleeding: Contrast extravasation may be seen in ongoing arterial or venous bleeding Muscle Appearance: Enlargement and edema of involved gluteal muscle Margins: Ill-defined in acute cases; better defined in organizing hematoma Associated Findings: Subcutaneous fat stranding, skin thickening, edema, or gas if infected Mass Effect: Compression of adjacent soft tissue planes or neurovascular structures Key Diagnostic Clue: Hyperdense intramuscular collection at the injection site with no solid enhancing component Finding:CT shows a hyperdense intramuscular collection within the gluteal musculature with surrounding soft tissue edema. No definite active contrast extravasation is identified.
Impression:CT features are consistent with post-injection gluteal intramuscular hematoma.
Recommendation:Urgent clinical evaluation is advised if active contrast extravasation, rapid enlargement, severe pain, hemodynamic instability, or neurological symptoms are present.
Limitation:Assessment may be limited by non-contrast-only CT, beam hardening artifact, or delayed presentation with altered hematoma density.
Pathology Features of Post-Injection Gluteal Hematoma:
Nature: Hemorrhagic soft tissue lesion Composition: Clotted blood, serum, fibrin, and degraded blood products Acute Phase: Fresh hemorrhage with clot formation Subacute Phase: Liquefaction and partial organization of hematoma Chronic Phase: Fibrous capsule, hemosiderin deposition, and organization may occur Inflammation: Mild surrounding inflammatory reaction may be present Infection: Secondary infection may produce abscess formation Neoplasm: No neoplastic tissue in uncomplicated hematoma Key Diagnostic Clue: Organized blood collection without solid tumor component Finding:Post-injection hematoma represents localized hemorrhage within muscle tissue due to vascular injury following injection.
Impression:Benign hemorrhagic intramuscular collection related to injection trauma.
Recommendation:Histopathology is generally not required unless imaging is atypical or a soft tissue tumor is suspected.
Limitation:Pathology is rarely available because diagnosis is usually clinical and radiological.
Differential Diagnosis / Mimics:
Gluteal Abscess: May show thick wall, internal debris, peripheral hyperemia, fever, and restricted diffusion on MRI Injection Granuloma: Chronic inflammatory nodule at injection site, often smaller and more solid Soft Tissue Sarcoma: Enhancing solid component, progressive growth, and lack of resolving clinical course Seroma: Simple fluid collection, usually anechoic and less hemorrhagic Fat Necrosis: Echogenic fat-containing lesion with possible calcification Myositis: Diffuse muscle inflammation without a discrete blood collection Morel-Lavallรฉe Lesion: Closed degloving injury usually located between subcutaneous fat and fascia Pseudoaneurysm: Shows Doppler flow with yin-yang pattern and neck communication
Key Point: Recent injection history, intramuscular location, blood-product appearance, and absent internal vascularity support hematoma.
Important Reporting Points:
1. Mention exact side: right or left gluteal region. 2. Identify involved muscle: gluteus maximus, medius, minimus, or subcutaneous plane. 3. Measure maximum dimensions in three planes. 4. Describe echogenicity/signal/density and stage of hematoma if possible. 5. State presence or absence of internal vascularity. 6. Look for active bleeding or contrast extravasation on CT if performed. 7. Mention surrounding edema, fat stranding, or skin thickening. 8. Comment on septations, liquefaction, debris, or fluid-fluid level. 9. Assess for secondary infection or abscess formation. 10. Recommend follow-up if lesion is large, symptomatic, atypical, or not resolving.
Differential Diagnosis / Mimics:
Gluteal Abscess: Thick wall, internal debris, peripheral hyperemia, fever, and pain. Injection Granuloma: Chronic inflammatory nodule at injection site, often small and solid-looking. Soft Tissue Sarcoma: Enhancing solid component, progressive growth, and atypical appearance. Seroma: Simple fluid collection, usually anechoic and non-hemorrhagic. Fat Necrosis: Echogenic fat-containing lesion with possible calcification. Myositis: Diffuse muscle inflammation without discrete hematoma collection. Morel-Lavallรฉe Lesion: Collection between subcutaneous fat and fascia after trauma. Pseudoaneurysm: Shows internal Doppler flow with yin-yang pattern.
Key Point: Recent injection history, intramuscular location, blood-product appearance, and absent internal vascularity support hematoma.
Case Study
Patient: 56-year-old male with painful swelling over the right buttock after intramuscular injection.
Ultrasound Findings: A heterogeneous avascular intramuscular collection measuring approximately 6.2 × 3.4 cm is seen within the right gluteus maximus muscle. Surrounding soft tissue edema is noted.
CT Findings: Hyperdense intramuscular collection is seen in the right gluteal region without definite active contrast extravasation.
MRI Findings: Intramuscular blood-product signal intensity with surrounding edema and no enhancing solid component.
Teaching Point: The combination of recent injection history, painful gluteal swelling, avascular intramuscular collection, and blood-product imaging appearance is diagnostic of post-injection hematoma.